Analysis of Cervical Cancer Early Diagnosis and Treat-ment in Shenzhen from 2018 to 2022
10.11735/j.issn.1004-0242.2024.12.A010
- VernacularTitle:2018-2022年深圳市宫颈癌早诊早治情况分析
- Author:
Yingyu ZHONG
1
;
Yingjie ZHANG
;
He WANG
;
Yueyun WANG
Author Information
1. 南方医科大学公共卫生学院,广东 广州 510000;深圳市妇幼保健院,广东 深圳 518000
- Keywords:
cervical cancer;
screening;
early diagnosis and treatment;
HPV vaccine;
Guangdong
- From:
China Cancer
2024;33(12):1027-1032
- CountryChina
- Language:Chinese
-
Abstract:
[Purpose]To analyze the fundamental data of cervical cancer screening,early diagno-sis,and treatment in Shenzhen from 2018 to 2022.[Methods]A retrospective analysis was con-ducted on data obtained from the Shenzhen Maternal and Child Health System's cervical cancer prevention and treatment information platform between January 2018 and December 2022,en-compassing a total of 2 419 037.Number of screening,detection rate,early diagnosis rate and treatment rate were calculated.[Results]The participation rate in the screening program exhibited a consistent annual increased from 2018 to 2022.Amongst the screened population,opportunistic screening accounted for 32.71％,government planned screening constituted 53.72％,while physi-cal examination-based screenings represented 15.83％.Notably,there were a total of 5 392 women diagnosed with CIN2 or above lesions;among them,there were also a total of 5 235 women diagnosed with CIN2+CIN3/carcinoma in situ+early-stage cancer.Furthermore,out of these cases identified through screening programs,a total of 4 996 women received appropriate treatment while only a small number(396)were lost to follow-up.The average detection rate for CIN2 and above lesions was found to be at an encouraging level of approximately 0.23％,with an impressive average early diagnosis rate reaching as high as 96.92％.Moreover,it was projected that from 2021 to 2022 the treatment rate exceeded 95％.[Conclusion]Since the start of HPV vaccination in China in 2017,the number of people participating in cervical cancer screening in Shenzhen has increased year by year,with the majority of government planned screening population.The early diagnosis rate and treatment rate have reached high levels after 2020.
